Compass Therapeutics stock plunges on trial data concerns, William Blair comments Apr 27, 2026 08:15AM
William Blair on Compass Therapeutics (CMPX) 75% Drop: 'This will raise questions on the approvability of this dataset' Apr 27, 2026 08:08AM
William Blair Reiterates Outperform Rating on Compass Therapeutics (CMPX) Mar 5, 2026 11:37AM
William Blair Starts Compass Therapeutics (CMPX) at Outperform Jan 5, 2026 04:31AM